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ABSTRACT 
The complexity of the mammalian brain requires highly specialised protein function and 
diversity. As neurons differentiate and the neuronal circuitry is established, several 
mRNAs undergo alternative splicing (AS) and other post-transcriptional changes that 
expand the variety of protein isoforms produced. Recent advances are beginning to shed 
light on the molecular mechanisms that regulate isoform switching during neurogenesis 
and the role played by specific RNA binding proteins in this process. Neurogenesis and 
neuronal wiring were recently shown to also be regulated by RNA degradation through 
nonsense-mediated decay. An additional layer of regulatory complexity in these 
biological processes is the interplay between AS and long noncoding RNAs. 
Dysregulation of post-transcriptional regulation results in defective neuronal 
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MAIN TEXT 
Post-transcriptional regulation generates protein diversity and specificity through a 
variety of integrated molecular processes (Fig. 1) (Lara-Pezzi and others 2013; Raj and 
Blencowe 2015). All adult tissues have a conserved and distinct expression profile that 
can be linked to their developmental program, but the post-transcriptional signature of 
the mammalian brain is unique. Tissue-dependent alternative splicing (AS) is 
predominant in neural tissues, and distinct splicing patterns appear to be regulated by 
brain-specific factors and are conserved across mammals, especially among primates 
(Ardlie and others 2015; Irimia and others 2014; Liu and others 2014; Merkin and others 
2012; Reyes and others 2013). Neural transcriptomes also predominate in the tissue-
specific expression of noncoding RNAs, which show the highest correlation between 
human and mouse (Necsulea and others 2014). Overall, the establishment of cellular 
identity in the brain appears to involve several layers of regulation and a unique 
differentiation program. Here we review recent findings on the regulation of neurogenesis 
and nervous-system development by alternative splicing (AS), nonsense-mediated decay, 
alternative polyadenylation, and other related post-transcriptional mechanisms and how 
dysregulation of these processes leads to neurodevelopmental disorders. 
 
Regulation of neurogenesis by alternative splicing 
Mechanism of alternative splicing 
During maturation of pre-mRNA into mRNA, introns are removed and exons are linked 
together in a process known as splicing. However, splicing is not a rigid process, and 
different mRNAs can be generated due to alternative splicing, such as exclusion of 
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specific exons from the mature mRNA, partial inclusion of exons due to alternative 5' or 
3' splicing sites, or intron retention (Lara-Pezzi and others 2013). AS is tightly regulated. 
Alternatively spliced exons and their flanking introns contain short nucleotide sequences 
called cis-regulatory motifs. These motifs are recognised in a sequence-specific manner 
by a class of RNA binding proteins (RBP) known as trans-regulatory splicing factors. 
Upon binding their target cis-regulatory motifs, trans-regulatory splicing factors either 
facilitate or preclude the assembly of the spliceosome on the exon, promoting its inclusion 
or exclusion (Lara-Pezzi and others 2013). Recent developments in RNA-sequencing and 
bioinformatics now allow deep transcriptomic analysis (Gatto and others 2014; Giudice 
and others 2016) that has unveiled the changes and regulation of AS and other post-
transcriptional processes operating during neurogenesis (Raj and Blencowe 2015).   
Contribution to neuronal wiring 
The precise impact of AS on mRNA and protein function is not fully understood. AS has 
been shown to affect protein domains that are subject to phosphorylation, thereby altering 
their regulation by cellular kinases (Merkin and others 2012). In addition, recent findings 
show that AS increases the number of proteins with which a given protein can interact, 
thereby expanding its potential functionality (Theer and others 2003; Wong and others 
2013; Yang and others 2016). This is particularly relevant in the context of neurogenesis, 
synaptic interactions, and the establishment of the neuronal network. For example, AS 
regulates the expression of diverse isoforms of Dscam (Down syndrome cell adhesion 
molecule), neurexins, and other adhesion proteins at the synapse that help to establish 
specific neuronal connections. In Drosophila, Dscam provides a prime example of the 
generation of thousands of alternative isoforms by AS. Dscam is a transmembrane protein 
that regulates neural circuit assembly mainly by avoiding interactions of neurons with 
themselves (self-avoidance). While heterophilic adhesion between different Dscam1 
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isoforms allows neuronal interaction, homophilic adhesion of the same isoform promotes 
repulsion. AS of Dscam1 is thought to take place in a probabilistic manner, rather than in 
a cell-type- or spatial-specific fashion (Miura and others 2013). This mechanism allows 
single cells to express Dscam1 isoforms that are different from those of their neighbouring 
neurons. When neurites, axons or post-synaptic elements from the same neuron try to 
interact with each other, homophilic interaction of the expressed Dscam1 isoform in this 
cell promotes repulsion and self-avoidance (Wu and others 2012). Dscam2 homophilic 
binding also promotes repulsion in most cells (Lah and others 2014), although it facilitates 
interactions between dendrites of L4 lamina neurons in the visual cortex and axons in 
their target cells (Tadros and others 2016). Therefore, different Dscam members pattern 
neuronal circuits by promoting either adhesion or repulsion. 
The role of Dscam in neuronal wiring has been well established in the fly; 
however, in mammals this role seems to be played by protocadherins, which are regulated 
not by AS but by alternative promoter usage (Raj and Blencowe 2015). AS also regulates 
neuronal interactions by controlling the expression of thousands of variants of the 
presynaptic adhesion protein neurexin (see below) (Reissner and others 2013; Treutlein 
and others 2014). 
 AS directs axonal guidance by generating various isoforms of the membrane 
receptors Robo3 and Dcc. Roundabout homologue (Robo) proteins are receptors for the 
secreted protein Slit, which prevents axons from crossing the midline during nervous 
system development. AS generates 2 Robo3 isoforms. Robo3.1 is unresponsive to Slit 
and inhibits expression of Robo1 and Robo2; its high expression in axons as they 
approach the midline allows them to enter the midline and cross it. Expression then 
switches to Robo3.2, which is sensitive to Slit and prevents midline re-entry (Leischner 
and others 2010). Robo3.2 protein is only expressed in distal axon regions. The amount 
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of Robo3.2 protein translated in the post-crossing growth cone is regulated by mRNA 
degradation through nonsense-mediated decay (NMD) (Chung and others 2013). Axon 
guidance is further regulated by AS of transcripts of the netrin receptor Dcc (deleted in 
colorectal carcinoma). Two Dcc isoforms are generated by AS, which differ in a linker 
sequence between two of the fibronectin repeats in its extracellular domain. Whereas both 
isoforms show similar affinity for netrin, binding of the ligand induces different 
ligand:receptor conformations for these two isoforms (Xu and others 2014). Dcc splicing 
is controlled, at least in part, by Nova. Knockout mice for this RBP show reduced 
expression of the longer Dcc isoform and a phenotype that resembles that of the Dcc 
knockout mice, including a delay in axon outgrowth and ventral projection to the midline 
(Davey and Tickle 2007). These developmental defects are rescued upon restoration of 
the long Dcc isoform expression, suggesting that the AS changes in this netrin receptor 
are responsible for the phenotype. Although the precise mechanism underlying the 
functional differences between both Dcc isoforms is not completely understood, the 
distinct conformation they adopt in response to netrin is thought to define their biological 
role.  
Alternative-splicing-dependent gene-expression programs 
AS was recently shown to control neurogenic transcription factors and epigenetic 
regulators. Lysine-specific demethylase 1 (LSD1) usually acts as a transcriptional co-
repressor together with REST (RE1 Silencing Transcription Factor) and histone 
deacetylases (HDACs) 1 and 2. The regular LSD1 isoform targets histone H3K4me1/2, 
whereas the neuron-specific AS isoform LSD1n mediates demethylation of H3K9 and 
H4K20 (Sanchez and others 2016; Schindelin and others 2012). Unlike LSD1, LSDn acts 
as a co-activator by interacting with Supervillin to promote expression of neurogenic 
genes and transcription factors like Egr1 and c-Fos (Rusconi and others 2016). Neuronal 
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activation alters the LSD1n/LSD1 ratio, and imbalance of these isoforms leads to 
hypoexcitability or hyperexcitability (Schmid and others 2010). The transcriptional 
program controlled by LSD1n is necessary for spatial learning and long-term memory 
formation and for a proper anxiety response (Rusconi and others 2016; Sanchez and 
others 2016). H3K9 is further regulated by the methyltransferase G9a, which also 
undergoes AS. Inclusion of G9a exon 10 favours nuclear localisation and neuronal 
differentiation (Fiszbein and others 2016). In addition to regulating chromatin 
remodelling proteins, AS regulates the activity of transcription factors. For example, AS 
of Pbx1 exon 7 can either repress or promote transcription of neuronal genes as 
differentiation progresses (Linares and others 2015). 
RNA binding proteins regulating alternative splicing during neurogenesis 
Neurogenesis and brain development are regulated by a network of AS trans-regulatory 
factors (Fig. 2), and alterations in the expression or stoichiometry of these RBPs may lead 
to neuronal impairment and disease. The trans-regulatory factor polypyrimidine tract-
binding protein 1 (PTBP1), expressed in neural stem cells (NSCs) and non-neuronal cells, 
prevents neuronal differentiation by repressing a variety of genes that regulate neural 
development (Zhang and others 2016). PTBP1 directly controls the expression of its 
paralogue PTBP2 by regulating the inclusion of exon 10. In the presence of PTBP1, this 
exon is skipped and a premature termination codon is introduced, resulting in PTBP2 
mRNA degradation through NMD (see below) (Makeyev and others 2007). As neuronal 
differentiation progresses, the neuron-specific miR-124 targets and inhibits PTBP1 
expression, leading to a strong increase in PTBP2 expression (Makeyev and others 2007). 
PBTP1 is itself regulated by AS. A newly detected brain-specific exon in PTBP1 mRNA 
(exon 14) introduces a premature STOP codon and promotes degradation of the mRNA 
through NMD (Vaquero-Garcia and others 2016). In addition, skipping of PTBP1 exon 
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9, a mammalian-specific splicing event, relaxes PTBP1-mediated repression of neural 
differentiation and activates the brain AS programme (Gueroussov and others 2015). 
Removal of the orthologous exon in chicken induces the expression of several isoforms 
previously identified in mammals.  
In neural progenitors, PTBP2 regulates cell proliferation and differentiation and 
prevents the premature activation of adult exons in the developing brain (Licatalosi and 
others 2012). Both PTBP1 and PTBP2 repress splicing of exon 18 in Postsynaptic density 
protein 95 (Psd-95) mRNA, which results in NMD of the transcripts and reduced protein 
expression in the developing brain (Zheng and others 2012). The downregulation of 
PTBP1 and PTBP2 during development allows PSD-95 to be translated and facilitates 
neuronal maturation and the establishment of glutamatergic synapses. PTBP1 further 
regulates this process by repressing splicing of the 3' intron of several mRNAs encoding 
presynaptic proteins, preventing their export to the cytoplasm (Yap and others 2012). 
Interestingly, inhibition of PTBP1 in fibroblasts induces neuronal reprogramming 
(Poguzhelskaya and others 2014). This is not achieved through changes in AS, but by 
regulating the interaction between microRNAs and their target mRNAs. PTBP1 competes 
with certain microRNAs and prevents inhibition of key repressive factors. PTBP1 
downregulation thus facilitates access of microRNAs to different components of the 
REST complex, which represses transcription of neuronal genes, thereby allowing 
differentiation to proceed. Full differentiation of reprogrammed cells also requires 
inhibition of PTBP2 by miR-9, which is induced by the transcription factor BRN2 (Susaki 
and others 2014). 
As neurogenesis progresses, expression of the neuronal-specific trans-regulatory 
factor nSR100 is switched on (Raj and others 2014). nSR100 takes over the control of 
PTBP1-regulated exons, facilitates the formation of pre-spliceosomal complexes, and 
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strongly promotes exon inclusion in mRNAs encoding neural proteins. nSR100 is also 
the major trans-regulatory factor controlling AS of microexons, small exons of 3-27 
nucleotides. Changes in microexon inclusion affect the protein-protein interaction 
domains of several proteins involved in neurogenesis (Irimia and others 2014). nSR100 
further controls neurogenesis by promoting AS of the transcriptional repressor REST. 
This favours expression of a low-activity REST isoform and thereby allows the 
expression of genes involved in neurogenesis (Raj and others 2011). 
Another major regulator of neurogenesis is RBFOX1. In NSCs, RBFOX1 controls 
both the expression and AS of genes involved in neuronal differentiation (Fogel and 
others 2012). These genes include transcription factors, other RBPs, and proteins 
involved in synaptic transmission and membrane excitation. In the cytoplasm, RBFOX1 
binds to the 3' untranslated region (UTR) of mRNAs involved in cortical development, 
stabilizing them and favouring their translation (Lee and others 2016). RBFOX1 loss-of-
function during development results in defective karyokinesis, which impairs radial 
migration and corticogenesis (Hamada and others 2015). RBFOX2, in contrast, has a 
more prominent role in the development of the cerebellum. Together with RBFOX1, 
RBFOX2 controls AS of the sodium channel Scn8a (Nav1.6) and is necessary for proper 
Purkinje cell pacemaking (Gehman and others 2012). RBFOX2 splicing is regulated by 
RBFOX3, resulting either in dominant-negative RBFOX2 forms or degradation of Rbfox2 
mRNA through NMD (Dredge and Jensen 2011). RBFOX3, recently identified as the 
neuronal marker recognized by the anti-NeuN antibody (Dredge and Jensen 2011), 
promotes neuronal differentiation by regulating AS of Numb (Kim and others 2013), a 
cell-fate determinant protein that controls, among other processes, NSC proliferation and 
self-renewal through the inhibition of Notch (Aguirre and others 2010). Numb AS is also 
controlled by RBM4 during neuronal differentiation in vitro (Tarn and others 2016). 
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RBFOX factors further promote neurogenesis by regulating Ninein AS, which switches 
from a centrosomal isoform in progenitor cells to a non-centrosomal form in neurons 
(Zhang and others). 
RBFOX1 often acts in combination with NOVA splicing factors to regulate 
neuronal development (Zhang and others 2010). NOVA family members regulate AS and 
nucleo-cytoplasmic shuttling and can be found associated with target mRNAs in dendrites 
(Racca and others 2010). NOVA factors also contribute to axon outgrowth and guidance 
in the cortex, brainstem, and spinal cord by controlling the splicing pattern of the 
membrane receptor Dcc and other mRNAs (Balaban and others 2012; Davey and Tickle 
2007). In addition to genes involved in synaptic functions, NOVA regulates AS of genes 
encoding protein kinases and phosphatases, thus influencing the protein phosphorylation 
pattern in neurons (Zhang and others 2010). 
Synapses are further regulated by a subset of homologous RBPs that include 
SAM68, SLM1, and SLM2, which regulate AS of the presynaptic receptor neurexin 
(Nrxn) (Ehrmann and others 2013; Iijima and others 2014; Iijima and others 2011; 
Traunmüller and others 2016). Neurexins are pre-synaptic adhesion proteins involved in 
synapse formation and neurotransmission (Reissner and others 2013). Though encoded 
by just 3 genes (Nrxn 1, 2, and 3), several structurally different neurexins are generated 
by AS. The identity of neurexin-interacting partners at the synapse is determined by 
inclusion or exclusion of exon 20 (termed alternatively spliced segment 4, AS4). In 
different neuronal subpopulations, AS4 is regulated by SAM68, SLM1, and SLM2. 
SLM2 knockout mice show synaptic plasticity defects that can be rescued by restoring 
correct AS4 splicing, underlining the functional consequences that can emerge from 
changes to a single AS event (Traunmüller and others 2016).  
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Loss of trans-regulatory splicing factors causes neurodevelopmental disorders 
Disruption of key RBPs involved in neuronal differentiation and wiring impairs proper 
brain development and causes neurodevelopmental disorders. Reduced expression of 
nSR100 and misregulation of microexon splicing are associated with autism spectrum 
disorder (ASD). In mice, loss of function of nSR100 results in a shift towards non-
neuronal splicing patterns, especially in microexons, that lead to several developmental 
defects in both the central and peripheral nervous system (Quesnel-Vallières and others 
2015). Interestingly, the neuritogenesis defect observed in nSR100 knockout neurons can 
be rescued simply by restoring a single nSR100-regulated microexon in Unc13b, which 
is involved in vesicle fusion and neurotransmitter release at the synapse (van de Bospoort 
and others 2012). 
ASD brains also show dysregulation of RBFOX1-controlled AS events (Voineagu 
and others 2011). Genetic studies in ASD patients have revealed mutations and copy 
number variations in RBFOX1 and other genes (Griswold and others 2015; Turner and 
others 2016; Xiong and others 2015). Deletions in the RBFOX1 gene cause predisposition 
to seizures and have been associated with epilepsy (Gehman and others 2011; Lal and 
others 2015; Lal and others 2013).  
 
Post-transcriptional regulation of neurogenesis by the exon junction complex 
The exon junction complex 
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After splicing, the new exon-exon junction is bound by a multiprotein complex known as 
the exon junction complex (EJC). The EJC is organized around four core proteins: 
eIF4A3, MAGOH, RBM8A/Y14, and MLN51/CASC3. The core EJC is assembled on 
the mRNA following the splicing reaction and is then exported with the mRNA to the 
cytoplasm (Hir and others 2016). The core EJC is able to interact with several proteins, 
forming large messenger ribonucleoproteins (mRNPs) involved in different post-
transcriptional processes including mRNA transport, AS, translation and nonsense 
mediated decay (NMD) (Hir and others 2016; Singh and others 2012). Defects in the EJC 
therefore impact several biological processes and can cause a variety of developmental 
malformations. 
The EJC is necessary for neuronal development 
A regulatory role in neurogenesis has recently begun to emerge for certain EJC core 
components (McMahon and others). During embryonic development, RBM8A is highly 
expressed in the subventricular zone (SVZ) and the cerebral cortex (Mao and others 2015; 
Zou and others 2015). RBM8A promotes proliferation of neural progenitor cells and 
prevents their differentiation (Zou and others 2015). The RBM8A interacting partner 
MAGOH controls neural progenitor cell proliferation and differentiation by regulating 
the expression of the microcephaly-associated protein Lis1 (Bi and others 2009). Lis1 
binds to microtubules and is necessary for the integrity of the mitotic spindle during cell 
division. Reduced MAGOH expression impairs the normal orientation of the mitotic 
division plane during NSC division, causing genomic instability and a delay in mitosis 
(Silver and others 2010). The resulting prolonged mitosis alters progenitor fate by 
promoting neurogenic or apoptotic divisions (Pilaz and others 2016). Reduced neuronal 
expression of another core EJC component, eIF4A3, results in defective mRNA transport 
to dendrites and alters the miniature excitatory postsynaptic currents at synapses (Giorgi 
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and others 2007). Loss-of-function of the eIF4A3-interacting factor CCDC174, on the 
other hand, leads to defective neuronal differentiation (Volodarsky and others 2015). 
Together, these results highlight the role of the EJC in the regulation of neuronal 
differentiation and neurogenesis. 
Defects in the EJC lead to neurodevelopmental disease 
Alterations to EJC components impair neurogenesis and lead to neurodevelopmental 
disorders. Microdeletions and duplications in the 1q21.1 region, where the RBM8A gene 
is located, are associated with different neurodevelopmental disorders, including brain 
size defects and autism (Brunetti-Pierri and others 2008). Rbm8a haploinsufficiency in 
the mouse brain causes a reduction in the number of progenitors and mature neurons, 
leading to defective cortical lamination and microcephaly (Mao and others 2015). 
Transcriptomic analysis revealed several genes whose expression and/or AS is regulated 
directly or indirectly by RBM8A, many of which have been implicated in autism and 
Alzheimer's disease (Zou and others 2015). Microcephaly is also a consequence of Magoh 
haploinsufficiency (Silver and others 2010), and Magoh heterozygous mutant mice have 
a lower-than-normal number of neurons and disorganized cortical layers. Interestingly, a 
recent study has found that haploinsufficient mice for Eif4a3 show similar aberrant 
neurogenesis and microcephaly to those observed in Magoh and Rbm8a mutant mice 
(Mao and others 2016). The lack of any of these three EJC core components results in the 
alteration of common pathways at the onset of neurogenesis, which affect p53, 
proteasome and ribosome components as well as splicing regulators. Interestingly, loss 
of p53 rescues the microcephaly phenotype in each of the mutant mice by restoring 
neuron number and distribution (Mao and others 2016).  
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Regulation of neurogenesis by nonsense-mediated decay 
The mechanism of nonsense-mediated decay  
NMD is an essential biological pathway that controls mRNA degradation and ultimately 
protein expression (Lykke-Andersen and Jensen 2015). The processing of some pre-
mRNAs by AS may introduce premature translation termination codons, and the resulting 
mRNAs are recognized by the NMD machinery and degraded (Fig. 3). The core NMD 
machinery includes the proteins UPF1, UPF2, and the two UPF3 paralogues UPF3A and 
UPF3B. The RNA helicase UPF1 recognises premature termination codons and nucleates 
the formation of the SURF complex. This complex is associated with the ribosome and 
includes eukaryotic release factors 1 and 3 (eRF1, eRF3), the RNA helicase DEAH box 
polypeptide 34 (DHX34), and the SMG1 complex (SMG1C, comprising SMG1, SMG8, 
and SMG9). When a termination codon appears upstream of the EJC bound to an exon-
exon junction, the EJC facilitates the recruitment of UPF2 and UPF3 and promotes the 
formation of the UPF1-UPF2-UPF3 complex (Lykke-Andersen and Jensen 2015; Singh 
and others 2012). This complex substitutes the ribosome-associated eRF1 and eRF3 and 
facilitates the formation of a decay-inducing complex and degradation of the mRNA (Hug 
and Cáceres 2014). Disruption of NMD leads to changes in gene expression that are 
associated with several diseases, including various forms of intellectual disability 
(Nguyen and others 2012). Interestingly, in the brain these changes often affect genes 
encoding RBPs and chromatin regulators, connecting AS and NMD to epigenetic 
regulation (Yan and others 2015). 
NMD is necessary for neurogenesis 
The control of protein expression by NMD contributes to the regulation of neurogenesis. 
UPF1 has recently been shown to promote proliferation and reduce differentiation of 
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neural progenitor cells. This effect is achieved by promoting the decay of mRNAs 
encoding a number of proteins that block proliferation and favour differentiation, 
including p21, p27, p57, and the TGF- signalling inhibitor SMAD7 (Lou and others 
2014). Expression of UPF1 is downregulated by miR-128 (Bruno and others 2011). As 
neuronal differentiation progresses, miR-128 is induced, resulting in NMD repression and 
enhanced expression of mRNAs that would otherwise be targeted for degradation. These 
mRNAs are involved in neuronal development and function and can be induced in NSCs 
by expression of miR-128. In an interesting negative feedback loop, UPF1 reduces miR-
128 expression by activating TGF- signalling (Lou and others 2014). UPF1 represses 
the expression of two additional microRNAs, miR-9 and miR-124, which in turn 
downregulate the NMD factor UPF3B. UPF3B itself reduces the expression of miR-9 and 
miR-128, further reinforcing the negative feedback loop (Lou and others 2014). The role 
of UPF3B in neurogenesis is complex and not entirely clear. While UPF3B depletion in 
neural progenitor cells induces their proliferation and blocks differentiation (Jolly and 
others 2013), loss of this factor in NSCs results in early differentiation (Lou and others 
2014). In contrast to UPF3B, its paralogue UPF3A has the opposite effect and acts as an 
NMD inhibitor by sequestering UPF2 (Shum and others 2016). UPF3A promotes 
expression of SMAD7 and other signalling intermediates, and generally has the opposite 
effect to UPF1. 
Alterations in NMD lead to neurodevelopmental defects and disease. 
Alterations of the core NMD mechanism are also associated with disease. Mutations in 
the UPF3B gene that cause degradation of its mRNA, and therefore reduced UPF3B 
protein expression, are associated with non-specific mental retardation, autism and 
intellectual disability (Jolly and others 2013; Laumonnier and others 2010). Abnormal 
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upregulation of coactivator-associated methyltransferase-1 (CARM1), which associates 
with UPF1 and facilitates its binding to premature stop codons on the mRNA, contributes 
to the development of spinal muscular atrophy by altering NMD of specific genes 
potentially involved in in this disease, which include ATF4 target genes, among others 
(Sanchez and others 2016). Loss-of-function mutations in SMG9 cause congenital 
anomalies that include brain atrophy and other developmental defects (Shaheen and 
others 2016). In contrast, NMD can be manipulated to improve neuron survival and 
function. The RBPs TDP-43 and FUS are abnormally upregulated in certain types of 
amyotrophic lateral sclerosis (ALS) due to defective NMD, causing motor neuron 
toxicity. In an ALS model induced by TDP-43, overexpression of UPF1 and UPF2 
enhances neuron survival by promoting degradation of TDP-43 through NMD (Barmada 
and others 2015). Furthermore, gene therapy based on adeno-associated virus 9 (AAV9)-
mediated overexpression of UPF1 improves forelimb function in a rat model of ALS 
induced by TDP-43. The beneficial effect of UPF1 overexpression on motor function in 
these animals likely derives from its neuroprotective effect, although the precise 
mechanism was not completely elucidated (Jackson and others 2015). Together, these 
results suggest that the NMD machinery is a potential therapeutic target.  
 
Regulation of neuronal differentiation and function by alternative polyadenylation 
Another post-transciptional mechanism that can impact neurogenesis is alternative 
polyadenylation (APA), which regulates mRNA localisation and translation and 
noncoding RNA activity. After transcription, the 3' end of the mRNA is cleaved and a 
polyA tail is added, favouring mRNA stability and export to the cytoplasm (Elkon and 
others 2013). The cleavage site in the mRNA is determined by the polyA signal. This 
Lara-Pezzi and others  NRO-16-RE-0049-R1 
Page 17 of 28 
 
nucleotide sequence is usually found at the mRNA 3' end. However, weaker polyA 
signals can also be found upstream in the mRNA. Selection of these alternative polyA 
signals results in a shorter mRNA and often in a smaller protein. 
APA is implicated in the regulation of the activity of the ubiquitin ligase Ube3a. 
Expression of this protein is induced by neuronal activity during the development of 
excitatory synapses by inducing degradation of ARC, which in turn promotes the 
internalisation of AMPA receptors at the synapse (Greer and others 2010). Alternative 
Ube3a polyadenylation results in an alternative transcript (Ube3a1) that produces a 
truncated protein with no catalytic activity, which regulates the switch from dendrite 
growth to spine maturation (Valluy and others 2015). Interestingly, this effect is not 
mediated by the protein itself, but by the 3'UTR of the mRNA; this region sequesters 
several microRNAs from the miR379-410 cluster and prevents them from binding other 
cellular mRNAs (Fiore and others 2009; Valluy and others 2015). 
Another prime example of a protein whose expression is regulated by APA is 
HuR, an RBP of the ELAV/Hu family. HuR is ubiquitously expressed and mainly 
promotes cell proliferation. HuR mRNA in the brain is longer than the variants found in 
other tissues; moreover, the longer HuR mRNA is less stable and is translated into protein 
less efficiently than shorter HuR mRNAs (Mansfield and Keene 2012). The longer HuR 
mRNA is produced upon binding of the neuronal ELAV/Hu proteins HuB, HuC and HuD 
to the polyadenylation site in the short HuR mRNA. This promotes the generation of an 
extended, nontranslated 3'UTR, thereby reducing proliferation and favouring neuron 
differentiation. 
APA is also important in the regulation of the localisation and translation of 
mRNAs in specific subcellular compartments. During neuronal differentiation, 
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muscleblind-like (Mbnl) proteins promote the use of distal polyadenylation sites that lead 
to alternative last exons that in turn facilitate mRNA localisation in neurites  (Taliaferro 
and others). 
 
Regulation of neurogenesis by the interplay between RBPs and noncoding RNAs 
Long noncoding RNAs (lncRNAs) are emerging as key regulators of several biological 
processes. However, their role in neurogenesis is still poorly understood. The lncRNA 
Pinky (Pnky) is specifically expressed in the nervous system. Pnky is enriched in NSCs 
in their adult niche in the SVZ and in the embryonic brain, and its expression decreases 
during differentiation (Ramos and others 2015). Pnky prevents NSC differentiation, and 
its knockdown results in expansion of the transit-amplifying population and neuronal 
differentiation, both in vitro and during embryonic development. Interestingly, Pnky 
binds PTBP1, which regulates AS during neurogenesis as described above. Knocking 
down Pnky or PTBP1 results in similar AS changes, suggesting that they participate in a 
common regulatory pathway. 
 Another lncRNA involved in neurogenesis is GOMAFU/MIAT (Aprea and others 
2013). GOMAFU binds the AS regulators SRSF1 and quacking (QKI), and its 
dysregulation induces AS changes in genes involved in brain development, such as 
Wnt7b (Aprea and others 2013; Barry and others 2014). In addition, GOMAFU is 
downregulated in schizophrenia (Barry and others 2014). The changes in the splicing 
pattern observed after GOMAFU manipulation resemble those associated with this 
condition, including those affecting the EGF receptor family member ErbB4 (Barry and 
others 2014; Chung and others 2016). GOMAFU is also downregulated in fear-
conditioned mice: GOMAFU knockdown in the medial prefrontal cortex derepresses 
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beta-crystallin B1 (Crybb1) expression and induces an anxiety-like behaviour (Genina 
and others 2010). Repression of Crybb1 transcription by GOMAFU is mediated by 
interaction with the chromatin remodelling protein Bmi1, suggesting that this lncRNA 
regulates epigenetic changes and AS. 
 
Conclusions and open challenges 
Post-transcriptional mRNA regulation impacts the various steps that regulate neuronal 
differentiation and shapes the neuronal network in the brain. Recent findings have 
implicated dysregulation of AS, NMD, and APA in neurodevelopmental disease, 
particularly in ASD. However, several key questions remain unanswered and additional 
research is needed to fully determine the role of these processes and how they are 
integrated. Although roles in neuronal differentiation and brain development have been 
identified for some RBPs, there are hundreds RBPs whose function remains to be 
investigated. Importantly, only a few of these proteins show neurospecific expression, 
and the mechanisms by which ubiquitously expressed RBPs regulate neuronal 
differentiation remains unclear. Also, whereas in-depth studies are revealing the role of 
microRNAs in neuronal development, our knowledge of other noncoding RNAs in this 
process is still very limited. In particular, the study of lncRNAs should provide fresh 
insight into the post-transcriptional regulation of neurogenesis. The impact of AS and 
APA on mRNA transport and compartmentalised translation is another field deserving 
additional attention, offering the possibility to explain not only global expression changes 
but also where in the cell these changes take place. Understanding how all these processes 
are regulated will open the door to new therapeutic developments targeting these 
processes.   
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Figure 1. Alternative splicing and related post-transcriptional regulatory 
mechanisms. During alternative splicing, inclusion or exclusion of an exon in the mature 
mRNA is regulated by cis-regulatory sequences and trans-regulatory factors. Cis-
regulatory sequences are short nucleotide motifs found in the alternatively spliced exon 
or its flanking introns. These sequences can promote either inclusion of the exon (intronic 
or exonic splicing enhancer, ISE, ESE) or its exclusion (intronic or exonic splicing 
silencer, ISS, ESS). Cis-regulatory sequences are recognised by transregulatory factors 
such as those of the SR or hnRNP protein families, which either promote or preclude the 
recruitment of the spliceosome. Long noncoding RNAs (lncRNAs) can interact with 
trans-regulatory splicing factors and regulate their activity. Changes in alternative 
splicing can lead to the production of a protein with a different structure, localisation, or 
function. mRNAs carrying premature translation termination codons introduced by 
alternative splicing are degraded through nonsense-mediated decay. The use of an 
alternative polyadenylation site (PAS) can lead to an alternative last exon in the mRNA, 
which may alter the transcript's localisation or its interaction with microRNAs. Adapted 
from (Lara-Pezzi and others 2013). 
 
Figure 2. Regulation of neuronal differentiation and the establishment of a neuronal 
network by trans-regulatory splicing factors. Trans-regulatory factors (elliptical 
boxes) regulate different steps of cellular differentiation and shape the brain circuitry by 
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regulating synapse formation through changes in AS, mRNA transport, and NMD. NSC, 
neural stem cells. 
 
Figure 3. Regulation of neuronal differentiation by core nonsense-mediated decay 
factors. UPF1 promotes degradation through NMD of factors inhibiting neural stem and 
progenitor cell proliferation, such as p21, p27, p57, and the TGF- signalling inhibitor 
SMAD7. In contrast, UPF3A sequesters UPF2 and inhibits NMD to promote expression 
of SMAD7 and genes involved in neuronal differentiation. UPF3B has been implicated 
in both NSC proliferation and neuronal differentiation.  
 
 
 
 
